An Ultra-Sensitive and Cost-Effective Assay
Minimal Residual Disease (MRD) refers to cancer cells that survive treatment and remain in the body. These cells may exist at such low levels that they don't cause noticeable signs or symptoms, but their presence indicates the cancer is not completely gone.
MRD provides critical insight into how much, if any, cancer remains in your body during treatment or reappears after treatment.
Monitoring your MRD status empowers you and your doctor to make informed decisions throughout your cancer journey. That’s where SmartRD comes in to help.
Non-Invasive Convenience
With SmartRD, you can monitor your cancer from the comfort of your home. Simply collect a saliva sample and mail it to us — we’ll take care of the rest.
Personalized Precision
SmartRD is tailored to your unique cancer genomics. It identifies specific markers associated with your disease, offering a level of accuracy no other test can match.
Continuous monitoring
Stay ahead of cancer with regular testing — quarterly or even monthly. Our detailed reports provide insights into what’s on the horizon, ensuring you’re always the first to know when action is needed.
Powered by Cutting-Edge Research
SmartRD leverages the latest advancements in genomics and bioinformatics to deliver unparalleled MRD monitoring and insights.